Nanomedicine in Action: An Overview of Cancer Nanomedicine on the Market and in Clinical Trials

Table 2

Half-life of ASNase (native versus PEGylated) [50].

Product	Manufacturer	𝑇1/2
E. coli native ASNase (Elspar)	Merck & Co. Inc.	1.15 days
PEG-ASNase (Oncaspar)	Enzon Pharmaceuticals	5.85 days